Listeria infection in patients on anti-TNF treatment: Report of two cases and review of the literature
作者： Cândida Abreu , Fernando Magro , Filipe Vilas-Boas , Susana Lopes , Guilherme Macedo
DOI: 10.1016/J.CROHNS.2012.04.018
关键词:
摘要: Listeria monocytogenes is an aerobic gram positive intracellular bacillus, predominantly affecting pregnant women, immunocompromised patients and old individuals. Invasive listeriosis, meningitis meningoencephalitis, bacteraemia with or without joint, eye heart focalization are clinical manifestations of the disease. Anti-TNF-α drugs blocking host's response against various microorganisms, particularly agents like monocytogenes, increase risk We report two cases L. in ulcerative colitis under infliximab plus steroids. One patient HIV-1 infected. A review reported invasive listeriosis anti-TNF also showed.
oup.com
mendeley.com
oxfordjournals.org参考文章(34)
José L Peña-Sagredo, María V Hernández, Nagore Fernandez-Llanio, Eugenio Giménez-Ubeda, Santiago Munoz-Fernandez, A Ortiz, MA Gonzalez-Gay, MC Fariñas, G Biobadaser, Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience Clinical and Experimental Rheumatology. ,vol. 26, pp. 854- 859 ,(2008)
JM Ramos, MF García-Sepulcre, M Masiá, A Brotons, MC Grau, F Gutiérrez, None, Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy. Revista Espanola De Enfermedades Digestivas. ,vol. 102, pp. 614- 616 ,(2010) , 10.4321/S1130-01082010001000014
A Nakane, T Minagawa, K Kato, Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infection and Immunity. ,vol. 56, pp. 2563- 2569 ,(1988) , 10.1128/IAI.56.10.2563-2569.1988
Léia CR Silva, Luciena CM Ortigosa, Gil Benard, Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy. ,vol. 2, pp. 817- 833 ,(2010) , 10.2217/IMT.10.67
Emma Culver, Simon Travis, How to manage the infectious risk under anti-TNF in inflammatory bowel disease. Current Drug Targets. ,vol. 11, pp. 198- 218 ,(2010) , 10.2174/138945010790310009
Theodoros Kelesidis, Amandeep Salhotra, Jorge Fleisher, Daniel Z. Uslan, Listeria endocarditis in a patient with psoriatic arthritis on infliximab: Are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections? Journal of Infection. ,vol. 60, pp. 386- 396 ,(2010) , 10.1016/J.JINF.2010.02.009
T. Glück, H.-J. Linde, J. Schölmerich, U. Müller-Ladner, C. Fiehn, P. Bohland, Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases. Arthritis & Rheumatism. ,vol. 46, pp. 2255- 2257 ,(2002) , 10.1002/ART.10374
Rado Manitrala Ramanampamonjy, David Laharie, Barbara Bonnefoy, Julien Vergniol, Michel Amouretti, Méningoencéphalite à Listeria monocytogenes au cours d’un traitement par infliximab d’une maladie de Crohn Gastroentérologie Clinique et Biologique. ,vol. 30, pp. 157- 158 ,(2006) , 10.1016/S0399-8320(06)73138-4
Joseph Morelli, Frederick A Wilson, Does administration of infliximab increase susceptibility to listeriosis The American Journal of Gastroenterology. ,vol. 95, pp. 841- 842 ,(2000) , 10.1016/S0002-9270(99)00931-4
Motohisa YAMAMOTO, Hiroki TAKAHASHI, Chie MIYAMOTO, Mikiko OHARA, Chisako SUZUKI, Yasuyoshi NAISHIRO, Hiroyuki YAMAMOTO, Yasuhisa SHINOMURA, Michio NONAKA, Kohzoh IMAI, [A case in which the subject was affected by Listeia meningoencephalitis during administration of infliximab for steroid-dependent adult onset Still's disease]. Japanese Journal of Clinical Immunology. ,vol. 29, pp. 160- 168 ,(2006) , 10.2177/JSCI.29.160